Home Home > Browse Locations > Italy

Find Paid Clinical Trials in Italy

Paid Clinical Trials and Focus Groups


Paid Clinical Trials in Italy

Top of Directory » All Locations » Italy


  • Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome

    Condition:   Sjögren's Syndrome
    Intervention:   Drug: LimphoStat-B
    Sponsors:   University of Udine;   Azienda Ospedaliera S. Maria della Misericordia
    Recruiting - verified November 2009

  • Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

    Condition:   Heart Failure
    Intervention:  
    Sponsor:   Cardiac Concepts, Inc.
    Recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Italian ClinicalService Project

    Conditions:   Arrhythmias, Cardiac;   Bradycardia;   Syncope
    Interventions:   Device: Implantable Cardioverter-Defibrillator (ICD);   Device: Implantable Pacemaker Generator (IPG);   Device: Implantable Loop Recorder (ILR);   Device: Cardiac Resynchronization Therapy-Defibrillator (CRT-D)
    Sponsor:   Medtronic Italia
    Recruiting - verified November 2009

  • Blood Sparing Strategies: Omni-stat Routinary Use in Cardiac Surgery. A Prospective Randomized Study.

    Condition:   Hemostasis
    Interventions:   Drug: Omni-stat Celox;   Drug: Control
    Sponsor:   Cardiochirurgia E.H.
    Not yet recruiting - verified November 2009

  • Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)

    Condition:   Periprocedural Myocardial Necrosis
    Intervention:   Drug: ROSUVASTATIN
    Sponsor:   University of Roma La Sapienza
    Not yet recruiting - verified November 2009

  • Gonadal Toxicity in Women With Hodgkin Lymphoma

    Condition:   Hodgkin Lymphoma
    Intervention:  
    Sponsor:   Gruppo Italiano Studio Linfomi
    Recruiting - verified November 2009

  • Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Saxagliptin;   Drug: Metformin
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • Probiotics and the Prevention of Traveler's Diarrhea

    Condition:   Travelers' Diarrhea
    Interventions:   Dietary Supplement: Protecflor;   Dietary Supplement: Placebo
    Sponsors:   Lallemand SAS;   Sprim Italy
    Not yet recruiting - verified October 2009

  • ELBA: Exemestane and Lapatinib in Advanced Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Drug: exemestane;   Drug: lapatinib
    Sponsor:   National Cancer Institute, Naples
    Not yet recruiting - verified October 2009

  • Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease

    Conditions:   Coronary Artery Disease;   Angioplasty, Transluminal, Percutaneous Coronary
    Intervention:   Device: Kaname cobalt-chromium coronary stent
    Sponsor:   Terumo Europe N.V.
    Not yet recruiting - verified October 2009

  • Low Salt Diet in Idiopathic Hypercalciuria

    Condition:   Hypercalciuria
    Interventions:   Behavioral: Low salt diet;   Behavioral: Water therapy alone
    Sponsors:   University of Parma;   Università Vita-Salute San Raffaele;   University of Milan;   Catholic University of the Sacred Heart
    Completed - verified October 2009

  • A Study of Pemetrexed and Bevacizumab for Patients With Advanced Non Small Cell Cancer

    Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Bevacizumab
    Sponsor:   Eli Lilly and Company
    Recruiting - verified October 2009

  • Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging

    Condition:   Non Muscle Invasive Bladder Cancer
    Interventions:   Procedure: NBI TUR;   Procedure: Standard TUR
    Sponsor:   National Institute for Cancer Research, Italy
    Recruiting - verified October 2009

  • POSTconditioning During Coronary Angioplasty in Acute Myocardial Infarction Study

    Condition:   Myocardial Reperfusion Injury
    Interventions:   Procedure: Postconditioning;   Procedure: Primary angioplasty and stenting without additional intervention
    Sponsor:   University of Padua
    Active, not recruiting - verified October 2009

  • Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity

    Condition:   Detrusor Overactivity
    Intervention:   Other: ultrasonography
    Sponsor:   Università degli Studi dell'Insubria
    Completed - verified October 2009

  • Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Aclidinium bromide;   Drug: Placebo
    Sponsors:   Almirall S.A.;   Forest Laboratories
    Recruiting - verified November 2009

  • Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Indacaterol;   Drug: Tiotropium
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009

  • Treatment of Depression in Acute Coronary Syndrome (ACS) Patients

    Condition:   Depression
    Intervention:   Behavioral: CBT in combination with WBT and life style modification
    Sponsors:   University of Bologna;   Compagnia San Paolo
    Not yet recruiting - verified October 2009

  • Removable Walker for Neuropathic Ulcers

    Condition:   Diabetic Foot
    Interventions:   Device: non-removable fiberglass;   Device: Stabil-D®
    Sponsor:   IRCCS Multimedica
    Completed - verified October 2009

  • Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas

    Conditions:   Ewing;   Soft Tissue Sarcoma
    Intervention:   Procedure: Allogeneic hemopoietic stem cell transplant
    Sponsors:   St. Orsola Hospital;   S. Anna Hospital
    Active, not recruiting - verified October 2009

  • Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients

    Conditions:   Medication Non-adherence;   Stent Thrombosis
    Intervention:  
    Sponsors:   Columbia University;   Bristol-Myers Squibb;   Sanofi-Aventis
    Recruiting - verified October 2009

  • Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin

    Condition:   Squamous Cell Carcinoma of the Head and Neck
    Interventions:   Drug: docetaxel - cisplatin - 5-fluorouracil;   Radiation: radiotherapy;   Drug: cetuximab;   Drug: cisplatin;   Radiation: radiotherapy
    Sponsor:   Gruppo Oncologico del Nord-Ovest
    Recruiting - verified October 2009

  • Lithium in Multiple System Atrophy

    Condition:   Multiple System Atrophy
    Intervention:   Drug: Lithium Carbonate
    Sponsor:   Federico II University
    Not yet recruiting - verified October 2009

  • Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)

    Condition:   Spinocerebellar Ataxia 2
    Intervention:   Drug: LITHIUM CARBONATE
    Sponsor:   Federico II University
    Not yet recruiting - verified October 2009

  • Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer

    Condition:   Cervical Cancer
    Interventions:   Drug: paclitaxel;   Drug: carboplatin;   Drug: cetuximab
    Sponsor:   National Cancer Institute, Naples
    Recruiting - verified October 2009

  • A Study of Tocilizumab in Combination With Disease-modifying Antirheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: DMARDs
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified October 2009

  • Surgical Treatment of Type 2 Diabetes Mellitus in <35 Body Mass Index (BMI)

    Conditions:   Type 2 Diabetes Mellitus;   Bariatric Surgery;   Biliopancreatic Diversion;   Gastric Bypass
    Intervention:   Procedure: biliopancreatic diversion, gastric bypass
    Sponsor:   Azienda Ospedaliera Universitaria San Martino
    Active, not recruiting - verified October 2009

  • Terlipressin in Septic Shock: Effects on Microcirculation

    Conditions:   Septic Shock;   Sepsis
    Interventions:   Drug: continuous infusion of terlipressin;   Drug: Arginine vasopressin;   Drug: terlipressin bolus administration
    Sponsor:   University of Roma La Sapienza
    Recruiting - verified October 2009

  • Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis

    Condition:   Behcet Disease
    Interventions:   Biological: AIN457;   Biological: AIN457;   Biological: Placebo
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009

  • NGR-hTNF Administered in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

    Condition:   Non-small Cell Lung Cancer
    Interventions:   Drug: NGR-hTNF;   Drug: cisplatin;   Drug: gemcitabine;   Drug: pemetrexed
    Sponsor:   MolMed S.p.A.
    Recruiting - verified October 2009

  • Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)

    Condition:   Pulmonary Arterial Hypertension
    Intervention:   Device: ACT-293987 (NS-304)
    Sponsor:   Actelion
    Completed - verified October 2009

  • Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

    Condition:   Pandemic Influenza Disease
    Intervention:   Biological: Monovalent A/H1N1 influenza vaccine
    Sponsors:   Novartis;   Novartis Vaccines
    Recruiting - verified October 2009

  • Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients

    Condition:   Hepatitis C
    Intervention:   Drug: ribavirin pre-treatment
    Sponsor:   University of Roma La Sapienza
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials